These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29330546)

  • 1. Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.
    de Groot-van der Mooren MD; Tamminga S; Oepkes D; Weijerman ME; Cornel MC
    Eur J Hum Genet; 2018 Feb; 26(2):157-165. PubMed ID: 29330546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
    Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
    Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening.
    Kurtovic-Kozaric A; Mehinovic L; Malesevic R; Mesanovic S; Jaros T; Stomornjak-Vukadin M; Mackic-Djurovic M; Ibrulj S; Kurtovic-Basic I; Kozaric M
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():79-83. PubMed ID: 27639605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of prenatal screening on the prevalence of Down syndrome in Slovenia.
    Rudolf G; Tul N; Verdenik I; Volk M; Brezigar A; Kokalj Vokač N; Jeršin N; Prosenc B; Premru Sršen T; Peterlin B
    PLoS One; 2017; 12(6):e0180348. PubMed ID: 28665986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
    Pescia G; Addor MC
    Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth prevalence of Down syndrome in Singapore from 1993 to 1998.
    Lai FM; Woo BH; Tan KH; Huang J; Lee ST; Yan TB; Tan BH; Chew SK; Yeo GS
    Singapore Med J; 2002 Feb; 43(2):070-6. PubMed ID: 11993893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands.
    Bouman K; Bakker MK; Birnie E; Ter Beek L; Bilardo CM; van Langen IM; de Walle HE
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):4. PubMed ID: 28056858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.
    Loane M; Morris JK; Addor MC; Arriola L; Budd J; Doray B; Garne E; Gatt M; Haeusler M; Khoshnood B; Klungsøyr Melve K; Latos-Bielenska A; McDonnell B; Mullaney C; O'Mahony M; Queisser-Wahrendorf A; Rankin J; Rissmann A; Rounding C; Salvador J; Tucker D; Wellesley D; Yevtushok L; Dolk H
    Eur J Hum Genet; 2013 Jan; 21(1):27-33. PubMed ID: 22713804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
    de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
    J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.
    Hartwig TS; Sørensen S; Jørgensen FS
    Prenat Diagn; 2016 Jul; 36(7):643-9. PubMed ID: 27135649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
    Lindquist A; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study.
    de Groot-van der Mooren M; de Graaf G; Weijerman ME; Hoffer MJV; Knijnenburg J; van der Kevie-Kersemaekers AMF; Kooper AJA; Voorhoeve E; Sikkema-Raddatz B; van Zutven LJCM; Srebniak MI; Huijsdens-van Amsterdam K; Engelen JJM; Smeets D; van Kaam AH; Cornel MC
    Prenat Diagn; 2021 Sep; 41(10):1351-1359. PubMed ID: 34176145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.
    van Gameren-Oosterom HB; Buitendijk SE; Bilardo CM; van der Pal-de Bruin KM; Van Wouwe JP; Mohangoo AD
    Prenat Diagn; 2012 Nov; 32(11):1035-40. PubMed ID: 22865545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).
    Savva GM; Walker K; Morris JK
    Prenat Diagn; 2010 Jan; 30(1):57-64. PubMed ID: 19911411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
    Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental Decisions about Prenatal Screening and Diagnosis among Infants with Trisomy 21 in a National Cohort with High Uptake of Combined First-Trimester Screening.
    Miltoft CB; Wulff CB; Kjærgaard S; Ekelund CK; Tabor A;
    Fetal Diagn Ther; 2017; 41(3):209-214. PubMed ID: 27455074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.